ZA978332B - 1-carba-(dethia)-cephalosporin derivatives. - Google Patents

1-carba-(dethia)-cephalosporin derivatives.

Info

Publication number
ZA978332B
ZA978332B ZA9708332A ZA978332A ZA978332B ZA 978332 B ZA978332 B ZA 978332B ZA 9708332 A ZA9708332 A ZA 9708332A ZA 978332 A ZA978332 A ZA 978332A ZA 978332 B ZA978332 B ZA 978332B
Authority
ZA
South Africa
Prior art keywords
dethia
carba
cephalosporin derivatives
cephalosporin
derivatives
Prior art date
Application number
ZA9708332A
Other languages
English (en)
Inventor
Peter Angehrn
Paul Hebeisen
Ingrid Heinze-Krauss
Malcolm Page
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA978332B publication Critical patent/ZA978332B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA9708332A 1996-09-23 1997-09-16 1-carba-(dethia)-cephalosporin derivatives. ZA978332B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96115210 1996-09-23

Publications (1)

Publication Number Publication Date
ZA978332B true ZA978332B (en) 1998-03-23

Family

ID=8223209

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9708332A ZA978332B (en) 1996-09-23 1997-09-16 1-carba-(dethia)-cephalosporin derivatives.

Country Status (23)

Country Link
US (1) US5939410A (xx)
JP (1) JPH10101670A (xx)
KR (1) KR100256473B1 (xx)
CN (1) CN1184110A (xx)
AR (1) AR008450A1 (xx)
AU (1) AU723176B2 (xx)
BR (1) BR9704770A (xx)
CA (1) CA2216222A1 (xx)
CO (1) CO4900072A1 (xx)
CZ (1) CZ292097A3 (xx)
HR (1) HRP970511A2 (xx)
HU (1) HUP9701548A3 (xx)
ID (1) ID18323A (xx)
IL (1) IL121798A0 (xx)
MA (1) MA26442A1 (xx)
NO (1) NO974366L (xx)
NZ (1) NZ328595A (xx)
PE (1) PE110098A1 (xx)
PL (1) PL322240A1 (xx)
SG (1) SG53049A1 (xx)
TR (1) TR199701011A2 (xx)
YU (1) YU38497A (xx)
ZA (1) ZA978332B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100093532A (ko) * 2007-10-25 2010-08-25 아카오젠, 인코포레이티드 카바세펨 β―락탐 항생제
WO2010030810A1 (en) * 2008-09-10 2010-03-18 Achaogen, Inc. Carbacephem beta-lactam antibiotics

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0112481A1 (en) * 1982-11-12 1984-07-04 Kyowa Hakko Kogyo Co., Ltd Beta-lactam compound
GB9213567D0 (en) * 1992-06-26 1992-08-12 Smithkline Beecham Plc Novel compounds
DK0620225T3 (da) * 1993-04-16 2003-03-17 Basilea Pharmaceutica Ag Cephalosporinderivater
BR9607046A (pt) * 1995-02-27 1997-12-30 Hoffmann La Roche Derivados de 3-pirrolidiliden-2-ona-cefalosporinas
EP0761673A1 (en) * 1995-09-12 1997-03-12 F. Hoffmann-La Roche Ag Cephalosporin derivatives

Also Published As

Publication number Publication date
IL121798A0 (en) 1998-02-22
BR9704770A (pt) 1998-11-03
MX9707201A (es) 1998-06-28
AU3838297A (en) 1998-01-15
TR199701011A2 (xx) 1998-04-21
AR008450A1 (es) 2000-01-19
NO974366D0 (no) 1997-09-22
NZ328595A (en) 1999-01-28
PE110098A1 (es) 1999-01-13
CA2216222A1 (en) 1998-03-23
YU38497A (sh) 1999-12-27
CO4900072A1 (es) 2000-03-27
HUP9701548A2 (hu) 1999-05-28
US5939410A (en) 1999-08-17
SG53049A1 (en) 1998-09-28
PL322240A1 (en) 1998-03-30
JPH10101670A (ja) 1998-04-21
KR19980024863A (ko) 1998-07-06
KR100256473B1 (ko) 2000-05-15
HUP9701548A3 (en) 2001-04-28
HU9701548D0 (en) 1997-11-28
HRP970511A2 (en) 1998-08-31
CZ292097A3 (cs) 1998-04-15
NO974366L (no) 1998-03-24
MA26442A1 (fr) 2004-12-20
ID18323A (id) 1998-03-26
AU723176B2 (en) 2000-08-17
CN1184110A (zh) 1998-06-10

Similar Documents

Publication Publication Date Title
ZA97521B (en) 19-Nor-pregnene derivatives.
ZA979593B (en) Naphthyridine derivatives.
ZA9710429B (en) Broad-spectrumδ-endotoxins.
ZA979199B (en) Aminothiophenecarboxamides.
ZA976168B (en) 3-Ureido-pyridofurans and -pyridothiophenes.
ZA977206B (en) Arylalkanoylpyridazines.
ZA976224B (en) 4-hydroxy-piperidine derivatives.
ZA978304B (en) 3-alkyl-3-phenyl-piperidines.
HK1018457A1 (en) Alkylaminobenzothiazole and-benzoxazole derivatives.
IL126624A0 (en) 3-descladinose-2, 3-anhydroerythromycin derivatives
ZA974953B (en) Substituted pyrazolylpyrazole derivatives.
ZA979725B (en) Benzoaxozole derivative.
ZA982436B (en) Thiazolimine derivatives.
ZA97572B (en) 1-pyrazol-3-ylethyl-4-indol-3-ylpiperidines.
ZA97928B (en) Novel heteroaryl-oxazolidinones.
ZA9710653B (en) 4-hydroxy-piperidine derivatives.
ZA974052B (en) New benzothiazolinones.
ZA976022B (en) Cycloalkano-pyridines.
ZA971167B (en) Heterocyclyl-ergoline derivatives.
CY2322B1 (en) Benzoaeguequinoline derivatives.
ZA971466B (en) Endothelin-receptor-antagonists.
ZA979781B (en) Piperidine derivatives.
ZA974056B (en) New thiazolopyridines.
ZA978332B (en) 1-carba-(dethia)-cephalosporin derivatives.
ZA972302B (en) 1,25-Dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives.